,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2017-07-07 02:04:00,The Zacks Research Daily presents the best research output of our analyst team.,0.6325156092643738,0.012341027148067951,0.35514333844184875,positive,0.6201745867729187
1,2017-07-07 02:04:00,"Today's Research Daily features new research reports on 16 major stocks, including Procter & Gamble (PG), Verizon (VZ), and Citigroup (C).",0.04241827130317688,0.008023626171052456,0.9495580792427063,neutral,0.03439464420080185
2,2017-07-07 02:04:00,These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.,0.054846275597810745,0.007339245639741421,0.937814474105835,neutral,0.04750702902674675
3,2017-07-07 02:04:00,"You can see all of today's research reports here >>>

Procter & Gamble 's shares have outperformed the Zacks Consumer Staples sector in the past year (+1.9% vs. -1.4%).",0.6625929474830627,0.31540268659591675,0.022004414349794388,positive,0.347190260887146
4,2017-07-07 02:04:00,"However, P&G shares have underperformed the S&P 500 index in the year-to-date period (up +3.9% vs. +7.8%).",0.23614513874053955,0.7454286217689514,0.018426280468702316,negative,-0.5092834830284119
5,2017-07-07 02:04:00,The company has been struggling to boost market growth for the last few quarters.,0.04908083751797676,0.9198678731918335,0.03105132281780243,negative,-0.8707870244979858
6,2017-07-07 02:04:00,"Also, significant negative forex impact has been hurting sales.",0.021304726600646973,0.9656021595001221,0.013093190267682076,negative,-0.9442974328994751
7,2017-07-07 02:04:00,But the Zacks analyst likes the fact that P&G is speeding up innovations and investments to counter softening industry growth.,0.8218693733215332,0.017717216163873672,0.16041336953639984,positive,0.8041521310806274
8,2017-07-07 02:04:00,Its productivity improvements and aggressive cost-saving efforts are also consistently helping to boost profit levels.,0.955689013004303,0.019098646938800812,0.025212347507476807,positive,0.9365903735160828
9,2017-07-07 02:04:00,(You can read the full research report on Procter & Gamble here >>> ) .,0.013788774609565735,0.010992237366735935,0.9752189517021179,neutral,0.0027965372428297997
10,2017-07-07 02:04:00,Shares of Verizon shares have been laggards over the past year -- the stock is down -22.1% over the past 12 months vs. AT&T's -12.7% decline and the +13% gain for the S&P 500 index.,0.019619140774011612,0.9678717255592346,0.012509223073720932,negative,-0.9482525587081909
11,2017-07-07 02:04:00,Verizon's underperformance reflects the market's concerns about the company's muddled strategy in the digital media domain and rising competitive pressures in its core U.S. wireless business.,0.022282840684056282,0.9592861533164978,0.018431106582283974,negative,-0.9370033144950867
12,2017-07-07 02:04:00,"The Yahoo purchase, as well as other previously acquired digital properties like AOL, Huffington Post will boost its digital media suite.",0.9424940347671509,0.015807785093784332,0.041698213666677475,positive,0.9266862273216248
13,2017-07-07 02:04:00,The long-term expectation is that these assets will give it a sizable enough platform to capture digital marketing dollars.,0.8751992583274841,0.011278331279754639,0.11352232098579407,positive,0.8639209270477295
14,2017-07-07 02:04:00,"The jury is still out on the long-term viability of these efforts, but the company is also trying to be a player in the online TV streaming space and defend its leadership position in the wireless market through 5G wireless network trials.",0.8304018378257751,0.014867228455841541,0.15473096072673798,positive,0.8155345916748047
15,2017-07-07 02:04:00,"The company's dividend appears safe (currently yields more than 5%), but the inherent capital intensity of its core business and the need for purchases on the digital side ends up eating up more than it generates in its operations.",0.3613734245300293,0.4321303963661194,0.2064962238073349,negative,-0.07075697183609009
16,2017-07-07 02:04:00,"In the updated research report issued today, the Zacks analyst discusses the pros and cons of investing in Verizon shares at present.",0.026870787143707275,0.007750341203063726,0.9653789401054382,neutral,0.01912044547498226
17,2017-07-07 02:04:00,(You can read the full research report onVerizonhere >>> ) .,0.012973709963262081,0.013049564324319363,0.9739766716957092,neutral,-7.58543610572815e-05
18,2017-07-07 02:04:00,"Citigroup 's shares have outperformed the Zacks categorized Major Regional Banks industry over the last six months, gaining +13.1% vs +6.8%.",0.8131977319717407,0.16337086260318756,0.02343137376010418,positive,0.6498268842697144
19,2017-07-07 02:04:00,"The Zacks analyst likes the company's restructuring and streamlining efforts, strategic investments in core business and expense management.",0.3978516757488251,0.012469571083784103,0.5896787047386169,neutral,0.38538211584091187
20,2017-07-07 02:04:00,The recent Fed approval of the company's 2017 capital plan is also encouraging.,0.8527716994285583,0.01413282472640276,0.1330954134464264,positive,0.8386389017105103
21,2017-07-07 02:04:00,"Moreover, the passage of the Financial Choice Act will act as a tailwind for the company in coming quarters.",0.4157126843929291,0.48119035363197327,0.10309691727161407,negative,-0.06547766923904419
22,2017-07-07 02:04:00,"However, several issues including litigation burden provide cause for concern.",0.023783324286341667,0.1819855272769928,0.7942311763763428,neutral,-0.15820220112800598
23,2017-07-07 02:04:00,Margins remain under pressure despite rising rates.,0.5488606691360474,0.2074364870786667,0.24370282888412476,positive,0.3414241671562195
24,2017-07-07 02:04:00,(You can read the full research report onCitigrouphere >>> ) .,0.014808004721999168,0.01587924174964428,0.9693127274513245,neutral,-0.001071237027645111
25,2017-07-07 02:04:00,"Other noteworthy reports we are featuring today include Albemarle (ALB), Kimberly-Clark (KMB) and Becton, Dickinson (BDX).",0.029294976964592934,0.005817870609462261,0.9648871421813965,neutral,0.023477107286453247
26,2017-07-07 02:04:00,Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007?,0.08660752326250076,0.09298931062221527,0.8204032182693481,neutral,-0.006381787359714508
27,2017-07-07 02:04:00,Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market.,0.8251555562019348,0.016993124037981033,0.15785132348537445,positive,0.8081624507904053
28,2017-07-07 02:04:00,Demand could soar from almost nothing to $42 billion by 2025.,0.8458088040351868,0.019966978579759598,0.13422414660453796,positive,0.8258418440818787
29,2017-07-07 02:04:00,"Reports suggest it could save 10 million lives per decade, which could in turn save $200 billion in U.S. healthcare costs.",0.6522005200386047,0.12595504522323608,0.2218443602323532,positive,0.5262454748153687
30,2017-07-07 02:04:00,A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it.,0.5342763066291809,0.015187621116638184,0.4505361020565033,positive,0.5190886855125427
31,2017-07-07 02:04:00,"Like Apple in 2007, these companies are already strong and coiling for potential mega-gains.",0.8605390787124634,0.019841492176055908,0.11961936950683594,positive,0.8406975865364075
32,2017-07-07 02:04:00,"Click to see them right now >>

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings.",0.12904183566570282,0.007992544211447239,0.8629655838012695,neutral,0.12104929238557816
33,2017-07-07 02:04:00,He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Previewreports.,0.022210685536265373,0.011222517117857933,0.966566801071167,neutral,0.01098816841840744
34,2017-07-07 02:04:00,"If you want an email notification each time Sheraz publishes a new article, please click here>>>

Per the Zacks analyst, lymphoma drug Adcetris has done well since launch.",0.9120992422103882,0.014746733009815216,0.07315404713153839,positive,0.8973525166511536
35,2017-07-07 02:04:00,Label expansion studies on the drug are ongoing.,0.09617722779512405,0.005290014669299126,0.8985326886177063,neutral,0.09088721126317978
36,2017-07-07 02:04:00,"However, competition is increasing in the lymphoma market.",0.7336843609809875,0.01658761128783226,0.24972805380821228,positive,0.717096745967865
37,2017-07-07 02:04:00,"Per the covering analyst, ReneSola is witnessing steady growth in its customer count that will help to expand its business.",0.9568070769309998,0.017151406034827232,0.026041535660624504,positive,0.9396556615829468
38,2017-07-07 02:04:00,"While the growing drilling demand and rig counts in the Permian and Bakken Shale plays in the Lower 48 region drive Nabors, the Zacks analyst is worried about the rising labor and reactivation costs.",0.03137524798512459,0.927465558052063,0.041159212589263916,negative,-0.8960903286933899
39,2017-07-07 02:04:00,"Per the covering analyst, the company will gain from its sustained efforts to amplify its product portfolio.",0.9507392048835754,0.01626449264585972,0.032996293157339096,positive,0.9344747066497803
40,2017-07-07 02:04:00,"Per the Zacks analyst, G&K Services' extended product portfolio and additional processing capacity will fuel Cintas' growth momentum, although raw material volatility remain potential headwinds.",0.9494051933288574,0.01818743348121643,0.03240736573934555,positive,0.9312177896499634
41,2017-07-07 02:04:00,"Though the restructuring at Hewlett Packard is a positive, lower demand for servers at enterprise and SMB segments due to the presence of virtualization and cloud options bothers the Zacks analyst.",0.023806197568774223,0.9567040801048279,0.019489800557494164,negative,-0.9328978657722473
42,2017-07-07 02:04:00,The Zacks analyst is bullish on the announced acquisition of C.R.,0.4153267443180084,0.03314705193042755,0.5515262484550476,neutral,0.3821796774864197
43,2017-07-07 02:04:00,Bard on expected synergies from complementary businesses and geographical expansion.,0.6993933916091919,0.012766456231474876,0.28784024715423584,positive,0.6866269111633301
44,2017-07-07 02:04:00,The Zacks analyst is impressed by the growth in Ryder's lease fleet.,0.9364382028579712,0.015057704411447048,0.04850408062338829,positive,0.9213805198669434
45,2017-07-07 02:04:00,The company's strong customer base is also a positive.,0.8407732844352722,0.014129413291811943,0.14509721100330353,positive,0.8266438841819763
46,2017-07-07 02:04:00,Efforts to reward shareholders also raise optimism in the stock.,0.9107282757759094,0.02330801635980606,0.06596370041370392,positive,0.8874202370643616
47,2017-07-07 02:04:00,"The Zacks analyst thinks that Albemarle is well placed to gain from expansion actions in its lithium unit, strong growth in the battery-grade lithium market and synergies of Rockwood Holdings buyout.",0.9528574347496033,0.015585431829094887,0.031557247042655945,positive,0.9372720122337341
48,2017-07-07 02:04:00,"Per the Zacks analyst, AXIS Capital is eyeing opportunities at Lloyds platform to accelerate growth rate.",0.9122719764709473,0.013934113085269928,0.073793925344944,positive,0.8983378410339355
49,2017-07-07 02:04:00,Addition of Novae Group plc places the acquirer into the top ten insurers' bracket at Lloyd.,0.2776740491390228,0.01040905062109232,0.7119169235229492,neutral,0.2672649919986725
50,2017-07-07 02:04:00,"Per the Zacks analyst, Kimberly-Clark has been witnessing increased competition in its diapers segment.",0.9453772902488708,0.023579038679599762,0.03104361891746521,positive,0.9217982292175293
51,2017-07-07 02:04:00,Slower organic sales growth in the emerging markets due to lower volumes also remain its woes.,0.02180376835167408,0.957925021648407,0.020271141082048416,negative,-0.9361212253570557
52,2017-07-07 02:04:00,"Per the Zacks analyst, Foot Locker's total sales and comps grew marginally in first-quarter fiscal 2017, a sharp contrast to fiscal 2016 performance.",0.14074645936489105,0.838157057762146,0.021096479147672653,negative,-0.6974105834960938
53,2017-07-07 02:04:00,"Further, soft second-quarter view raises concern.",0.10013139992952347,0.7617127299308777,0.13815580308437347,negative,-0.6615813374519348
54,2017-07-07 02:04:00,"The Zacks analyst believes that Teradyne's hard-disk drive (HDD) business will remain sluggish due to the weakness in the computing market, which is the primary consumer of HDDs.",0.02987690083682537,0.7061747908592224,0.26394832134246826,negative,-0.6762979030609131
55,2017-07-07 02:04:00,Want the latest recommendations from Zacks Investment Research?,0.03539300337433815,0.011573811061680317,0.9530332088470459,neutral,0.023819193243980408
56,2017-07-07 02:04:00,"Today, you can download 7 Best Stocks for the Next 30 Days.",0.05069372057914734,0.007019792217761278,0.9422864317893982,neutral,0.04367392882704735
57,2017-07-07 02:04:00,"Click to get this free report

To read this article on Zacks.com click here.",0.020684564486145973,0.03315984085202217,0.9461556077003479,neutral,-0.012475276365876198
58,2017-07-07 02:04:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204561054706573,0.01563790813088417,0.9741575717926025,neutral,-0.005433347076177597
